SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,078,194,480.417637 in circulation. The last known price of Algorand is 0.09693394 USD and is up 3.39 over the last 24 hours. It is currently trading on 586 active market(s) with $57,858,585.39 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

ALGOs weak price action near key resistance and its prolonged decline are driving a technical debate: bearish traders see limited momentum and risk of further losses, while bulls call the pullbacks accumulation ahead of a possible altcoin recovery. Some bullish discussion also points to the new leadership and Algorands quantum-security and tokenization themes, though these are presented as longer-term prospects.

Alcoa Corp. engages in the bauxite mining, alumina refining, and aluminum smelting and casting. It operates through the Alumina and Aluminum segments. The Alumina segment consists of a refining system, including the mining of bauxite, which is then refined into alumina, a compound of aluminum and oxygen that is the raw material used by smelters to produce aluminum metal. The Aluminum segment is composed of smelting and casthouse system. The company was founded by Charles Martin Hall on July 9, 1886 and is headquartered in Pittsburgh, PA.

Alcoa Corp

Unusual options activity and volatile trading have traders divided over Alcoas direction: some expect further cyclical downside, while others point to long-term aluminum demand and expanded assets as reasons for optimism. The discussion also weighs alumina-price exposure and financing and closing considerations around the companys acquisition plans.

NextDecade Corp. is a development company, which focuses on liquefied natural gas (LNG) export projects and associated pipelines. It develops and manages land-based and floating liquefied natural gas projects in the Gulf Coast with focus on the Rio Grande LNG. The company was founded by Kathleen Eishbrenner in 2010 and is headquartered in Houston, TX.

NextDecade Corporation

Geopolitical disruption to Qatari and Middle Eastern LNG supplies has focused traders on NextDecade as a potential future U.S. LNG supplier, alongside progress at its Rio Grande project and anticipated first production in 2027. Bulls see tighter supply and stronger contracting prospects as supportive, while skeptics point to the companys lack of current production and ongoing construction, financing, and execution risks.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshires latest quarterly results are drawing attention, with weaker insurance performance weighing on operating earnings while a sharp increase in share repurchases is viewed by supporters as a sign management sees value in the stock. The community is split between welcoming the buybacks and questioning whether they offset the earnings softness and limited investment opportunities.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels SITC clinical and biomarker updates across its prostate, lung and glioblastoma programs have renewed attention, alongside expectations for a Q4 BLA filing for CAN-2409 after positive Phase 3 prostate results. Bulls see the data and regulatory milestone as potential value drivers, while skeptics focus on filing uncertainty, CEO transparency and dilution risk.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

A reported, non-binding AstraZeneca offer for Rhythm Pharmaceuticals is driving deal chatter, with traders debating whether a transaction will materialize and whether AZN should pursue other obesity assets. The discussion frames the potential deal as an expansion of its rare-disease and obesity portfolio, but its outcome remains uncertain.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

MAGS is drawing attention as traders debate a rotation between mega-cap tech and semiconductor/AI-infrastructure stocks, amid concern that heavy AI spending could pressure the Magnificent Sevens returns. Some see the baskets pullback as a buying opportunity and potential return to leadership, while others warn that weak momentum and doubts about AI monetization could prolong the decline.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian shares are sliding despite an earnings beat, as traders focus on a much slower full-year growth outlook and expected weakness in Data Center. The selloff has sparked debate over whether cautious guidance and AI-related pressure on per-seat software justify the reaction, or whether the market is overreacting to an otherwise strong quarter.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirms results and outlook beat expectations, but shares sold off as traders focused on rising delinquencies, credit-loss provisions and funding costs. Bulls called the reaction an overdone response to strong growth, while skeptics questioned consumer credit quality and its effect on profitability.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

KWEB is drawing attention amid volatile China-tech trading and speculation that a U.S.-China deal or renewed access to Nvidia chips could support Chinese internet stocks; a sharp rally quickly reversed, fueling frustration and doubts that the move will last. The community remains split between buyers citing oversold valuations and Chinas AI potential and skeptics pointing to the sectors prolonged weakness and policy and geopolitical risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 91.1% to $6.04 during Friday's after-market session. The company's market cap stands at $2.2 million.
BGM Group (NASDAQ:BGM) stock rose 11.63%read more...

BGM Group (NASDAQ:BGM) Stock Price Down 1% - Should You Sell?

BGM Group (NASDAQ:BGM) Stock Price Down 1% - Here's What Happened...

BGM Group (NASDAQ:BGM) Trading Down 1.9% - What's Next?

BGM Group (NASDAQ:BGM) Shares Down 1.9% - Should You Sell...

BGM Group (NASDAQ:BGM) Reaches New 1-Year Low - Here's What Happened

BGM Group (NASDAQ:BGM) Sets New 1-Year Low - Here's What Happened...

BGM Group (NASDAQ:BGM) Stock Price Up 6.8% - Time to Buy?

BGM Group (NASDAQ:BGM) Shares Up 6.8% - Here's Why...

BGM Group (NASDAQ:BGM) Stock Price Down 11.7% - What's Next?

BGM Group (NASDAQ:BGM) Shares Down 11.7% - Time to Sell...

BGM Group (NASDAQ:BGM) Reaches New 1-Year Low - Time to Sell?

BGM Group (NASDAQ:BGM) Hits New 1-Year Low - Should You Sell...

BGM Group (NASDAQ:BGM) Trading Down 5% - Here's Why

BGM Group (NASDAQ:BGM) Trading Down 5% - What's Next...

BGM Group (NASDAQ:BGM) Shares Up 4.9% - Time to Buy?

BGM Group (NASDAQ:BGM) Stock Price Up 4.9% - Time to Buy...

BGM Group (NASDAQ:BGM) Shares Down 3% - Should You Sell?

BGM Group (NASDAQ:BGM) Trading Down 3% - Time to Sell...

BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. It operates through the following segments: Oxytetracycline and Licorice Products, and Traditional Chinese Medicine Derivatives (TCMD); Heparin Products and Sausage Casing; and Fertilizer. The Oxytetracycline and Licorice Products, and TCMD segment focuses on the development, manufacture, marketing, and sale of oxytetracycline products, licorice products, and TCMD. The Heparin Products and Sausage Casing segment treats cardiovascular diseases, cerebrovascular diseases, and hemodialysis. The Fertilizer segment includes Xiongguan, Organic Fertilizer and Xiongguan, and Organic-Inorganic Compound Fertilizer. The company was founded on February 7, 2019 and is headquartered in Chengdu, China.

BGM Group Ltd. - Ordinary Shares - Class A

Neutral Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$8.25
Prev Close	$9.00
Open	$8.25
Dividend Yield	0.00%
50-Day Moving Average	$8.62
Beta	0.75
Avg. Volume	11,586.49
PE Ratio	-1.72

52-Week High	$291.30
52-Week Low	$6.45
Market Capitalization	$110.17M
EPS (Annual)	-$5.28
Price to Book	0.14
Revenue Per Employee	$80,508.33

Feed

News

Sentiment

Earnings

Fundamentals

Info

BGM Fundamentals